Search

everythinglearnresearchcommunity

for

Search:↓

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

MPZL3 is crucial for seborrheic dermatitis development.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Eating grape powder may reduce the severity of skin allergy symptoms.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Sonic Hedgehog helps keep skin and airway barriers healthy and reduces inflammation.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Exosome-based therapies show promise for treating alopecia areata but need more research.